Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia (Sep, 10.1007/s00277-020-04269-y, 2020)

被引：0
|
作者：
Wan, Ke [1 ]
Yin, Yafei [2 ]
Luo, Zimian [2 ]
Cheng, Jianzhao [1 ]
机构：
[1] Xiangtan Cent Hosp, Dept Nephrol, Xiangtan, Hunan, Peoples R China
[2] Xiangtan Cent Hosp, Dept Hematol, Xiangtan 411100, Hunan, Peoples R China
来源：
ANNALS OF HEMATOLOGY | 2021年 / 100卷 / 01期
关键词：
D O I：
10.1007/s00277-020-04300-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The article "Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia", written by Ke Wan, Yafei Yin, Zimian Luo and Jianzhao Cheng, was originally published online on September 17, 2020 with Open Access under a Creative Commons Attribution (CC BY) license 4.0.
引用
收藏
页码：305 / 305
页数：1
相关论文
共 14 条
  • [1] Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia
    Wan, Ke
    Yin, Yafei
    Luo, Zimian
    Cheng, Jianzhao
    ANNALS OF HEMATOLOGY, 2021, 100 (02) : 591 - 593
  • [2] Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia
    Ke Wan
    Yafei Yin
    Zimian Luo
    Jianzhao Cheng
    Annals of Hematology, 2021, 100 : 591 - 593
  • [3] Correction to: Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia
    Ke Wan
    Yafei Yin
    Zimian Luo
    Jianzhao Cheng
    Annals of Hematology, 2021, 100 : 305 - 305
  • [4] Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia
    Xu, Bojun
    Liu, Suying
    Li, Yan
    Zhao, Liangbin
    Song, Xinyao
    Chen, Tong
    CLINICAL KIDNEY JOURNAL, 2021, 14 (11) : 2444 - 2445
  • [5] Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with hematide
    Macdougall, I. C.
    Casadevall, N.
    Stead, R. B.
    Froissart, M.
    Johnson, C.
    Duliege, A-M
    Eckardt, K-U
    NEPHROLOGY, 2008, 13 : A6 - A6
  • [6] Roxadustat Improves Erythropoietin Antibody-Mediated Pure Red Cell Aplasia in a Patient with Hemodialysis
    Li, Sijia
    Chen, Xueqin
    Hu, Penghua
    Wu, Suijing
    Ma, Jianchao
    Li, Zhuo
    Wu, Xiuchuan
    Wen, Feng
    Fu, Xia
    Feng, Zhonglin
    Tao, Yiming
    Li, Bohou
    Fu, Lei
    Huang, Renwei
    He, Chaosheng
    Shi, Wei
    Liang, Xinling
    Liu, Shuangxin
    BLOOD PURIFICATION, 2022, 51 (02) : 189 - 192
  • [7] Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone
    Aoki, Kazunari
    Ono, Yuichiro
    Tabata, Sumie
    Matsushita, Akiko
    Ishikawa, Takayuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 272 - 274
  • [8] Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone
    Kazunari Aoki
    Yuichiro Ono
    Sumie Tabata
    Akiko Matsushita
    Takayuki Ishikawa
    International Journal of Hematology, 2013, 97 : 272 - 274
  • [9] Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: Recommendations for minimization of risk
    Cournoyer, D
    Toffelmire, EB
    Wells, GA
    Barber, DL
    Barrett, BJ
    Delage, R
    Forrest, DL
    Gagnon, RF
    Harvey, EA
    Laneuville, P
    Patterson, BJ
    Poon, MC
    Posen, GA
    Messner, HA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (10): : 2728 - 2734
  • [10] Roxadustat on anti-erythropoietin antibody-related pure red cell aplasia in the patient with end-stage renal disease
    Wu, Rui
    Peng, Yanqiang
    SEMINARS IN DIALYSIS, 2021, 34 (04) : 319 - 322
12